TIGECYCLINE

SynDRA canonical compound SYN0006793 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	bacterial 30S ribosomal subunit inhibitor \| bacterial 30s ribosomal subunit inhibitor, bacterial dna inhibitor \| bacterial dna inhibitor
Indication	gram-negative bacterial infections \| intra-abdominal infections \| pneumonia \| skin infections \| skin infections, pneumonia, intra-abdominal infections, gram-negative bacterial infections
Disease area	infectious disease \| infectious disease \| Infectious disease \| infectious disease, Infectious disease

All known targets

CL 331002
tygacil
glycylcycline
Tigeciclina
WAY-GAR-936
Tigecycline accord
Tygacil
Tigilcycline
Tigecycline [USAN]
GAR-936
TBG-MINO
Tygacil (TN)
Tygacil(TM)
GAR-936,Tigecycline
Tigecycline (JAN/USAN)
Tygacil, GAR-936, WAY-GAR-936, TBG-MINO, Tigecycline
N-[(5aR,6aS,7S,9Z,10aS)-9-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-1,10a,12-trihydroxy-8,10,11-trioxo-5a,6,6a,7-tetrahydro-5H-tetracen-2-yl]-2-(tert-butylamino)acetamide
(4S,12aS)-4,7-Bis(dimethylamino)-9-{2-[(tert-butyl)amino]acetylamino}-3,10,12,12a-tetrahydroxy-1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide
(4S,4aS,5aR,12aS)-9-(2-(tert-butylamino)acetamido)-4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
(4S,4aS,5aR,12aS)-9-[(N-tert-butylglycyl)amino]-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
9-t-Butylglycylamido minocycline
GAR 936
MFCD00935753
CHEBI:149836
C29H39N5O8
tiglicycline
Tigecycline?
Tigecycline CRS
Haizheng Li Xing
Tigecycline 95%
NCGC00183095-01
T1C
Tigecycline (Standard)
Tigecycline (JAN/USP)
TIGECYCLINE [MI]
TIGECYCLINE [INN]
TIGECYCLINE [JAN]
TIGECYCLINE [VANDF]